NotesFAQContact Us
Collection
Advanced
Search Tips
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ944788
Record Type: Journal
Publication Date: 2007-Aug
Pages: 8
Abstractor: As Provided
Reference Count: N/A
ISBN: N/A
ISSN: ISSN-0890-8567
Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment
Subramaniam, Geetha A.; Stitzer, Maxine A.; Clemmey, Philip; Kolodner, Ken; Fishman, Marc J.
Journal of the American Academy of Child & Adolescent Psychiatry, v46 n8 p1062-1069 Aug 2007
Objective: To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes. Method: In total, 153 adolescents (mean age 6.6 years, plus or minus 0.11) entering residential treatment were assessed at intake and at 3, 6, 9, and 12 months. Beck Depression Inventory (BDI) and Global Appraisal of Individual Needs were administered to assess depression, other risk factors, and substance use. A regression model was developed with 10 risk factors including BDI scores of greater than or equal to 11 versus less than 11 to predict the outcome measure mean percentage of days in the past 90 days with any (nonnicotine) substance use. Results: At intake, 55% had BDI scores of greater than or equal to 11. A baseline BDI score of greater than or equal to 11 was significantly associated with greater mean percentage of days of substance use (27.5 plus or minus 3.8% versus 15.4 plus or minus 4.0% days, p less than 0.01) across 1-year follow-up. Two other factors were significant: length of drug career greater than 2 years and having an opioid use disorder. Conclusions: Results from this prospective study, although preliminary, suggest the association of depressive symptoms with poorer substance outcomes and the utility of the BDI as a prognostic tool. They highlight the need for interventions targeting co-occurring depressive symptoms that may improve adolescent substance treatment outcomes. (Contains 2 tables and 1 figure.)
Elsevier. 6277 Sea Harbor Drive, Orlando, FL 32887-4800. Tel: 877-839-7126; Tel: 407-345-4020; Fax: 407-363-1354; e-mail: usjcs@elsevier.com; Web site: http://www.elsevier.com
Publication Type: Journal Articles; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A
Identifiers - Assessments and Surveys: Beck Depression Inventory